TP53 and ovarian carcinoma: These data suggested that invasive ovarian cancer at early stages (FIGO I and II) are associated with p53 alterations, whereas the progression of ovarian cancer to distant metastases (FIGO III and IV) is associated with tumours having nuclear WT1 expression.